CLINICAL_TRIALS
withdrawal
· 2025-03-06
Clinical Trial Update: MAGIK for Femoral/Tibial Shaft Fractures [Phase 2]
Summary
A Phase 2 clinical trial named MAGIK for femoral and tibial shaft fractures has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Femoral Shaft Fracture, Tibial Shaft Fracture | Phase 2 | Status: WITHDRAWN